Abstract
Initial oral therapy for BPS can include amitriptyline, cimetidine, hydroxyzine, and/or pentosan polysulfate sodium. Cyclosporine should be reserved for use by experienced clinicians after less potentially morbid alternatives have been exhausted. Few of the oral therapies commonly used for the treatment of BPS have unequivocal evidence of efficacy in large, multicenter, randomized controlled clinical trials. There is little evidence that any change the natural history of the disease, though many seem to be effective in relieving symptoms in individual patients. Tachyphylaxis may be a problem.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barrington JW, Stephenson TP. Pentosanpolysulphate for interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(5):293–5.
Fritjofsson A, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol. 1987;138(3):508–12.
Holm-Bentzen M, Jacobsen F, Nerstrom B, Lose G, Kristensen JK, Pedersen RH, et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol. 1987;138(3):503–7.
Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol. 1983;130(1):51–3.
Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology. 1990;35(6):552–8.
Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol. 1993;150(3):845–8.
Sairanen J, Hotakainen K, Tammela TL, Stenman UH, Ruutu M. Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium. Urology. 2008;71(4):630–3.
Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810–5.
Nickel J, Barkin J, Forrest J, Mosbaugh P, Payne C, Hernandez-Graulau J, et al. k. Urology. 2001;165(5 (suppliment)):67A.
Jepsen JV, Sall M, Rhodes PR, Schmidt D, Messing E, Bruskewitz RC. Long-term experience with pentosanpolysulfate in interstitial cystitis. Urology. 1998;51(3):381–7.
Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology. 1997;49(5A Suppl):93–9.
Rice L, Kennedy D, Veach A. Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia. J Urol. 1998;160:2148.
Zaslau S, Riggs DR, Jackson BJ, Adkins FC, John CC, Kandzari SJ, et al. In vitro effects of pentosan polysulfate against malignant breast cells. Am J Surg. 2004;188(5):589–92.
Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol. 1997;79(2):168–71.
Hampson SJ, Woodhouse CRJ. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients. Eur Urol. 1994;25:40–2.
Parsons CL. Successful management of radiation cystitis with sodium pentosanpolysulfate. J Urol. 1986;136:813–4.
Toren P, Norman R. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulfate. J Urol. 2005;173:103.
Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman SS, Rall TW, et al., editors. The Pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company; 1985. p. 387–445.
Barrett DM, Wein AJ. Voiding dysfunction: diagnosis, classification, and management. In: Gillenwater JY, Grayhack JT, Howards SS, et al., editors. Adult and pediatric urology. Chicago: Year Book Medical Publishers; 1987. p. 863–92.
Hanno PM, Wein AJ. Medical treatment of interstitial cystitis (other than Rimso-50/Elmiron). Urology. 1987;29(4 Suppl):22–6.
Renshaw DC. Desipramine for interstitial cystitis. JAMA. 1988;260(3):341.
Hanno PM, Buehler J, Wein AJ. Use of amitriptyline in the treatment of interstitial cystitis. J Urol. 1989;141(4):846–8.
Hanno PM. Amitriptyline in the treatment of interstitial cystitis. Urol Clin North Am. 1994;21(1):89–91.
Kirkemo AK, Miles BJ, Peters JM. Use of amitriptyline in the treatment of interstitial cystitis. J Urol. 1990;143:279A.
Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology. 1998;51(5A Suppl):179–81.
van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533–6.
van Ophoven A, Hertle L. Long term results of amitriptyline treatment for interstitial cystitis. J Urol. 2005;173(4):86.
Hertle L, Van OA. Long-term results of amitriptyline treatment for interstitial cystitis. Aktuelle Urol. 2010;41 Suppl 1:S61–5.
Foster Jr HE, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–8.
McQuay HJ, Moore RA. Antidepressants and chronic pain. BMJ. 1997;314(7083):763–4.
Low PA, Dotson RM. Symptomatic treatment of painful neuropathy. JAMA. 1998;280:1863–4.
Ray W, Meredith S, Thapa P, Hall K, Murray K. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75:234–41.
Wammack R, Remzi M, Seitz C, Djavan B, Marberger M. Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis. Eur Urol. 2002;41(6):596–600.
van Ophoven A, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J Urol. 2007;177(2):552–5.
Simmons JL. Interstitial cystitis: an explanation for the beneficial effect of an antihistamine. J Urol. 1961;85:149–55.
Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am. 1994;21(1):113–9.
Simons F. Advances in H1-antihistamines. N Engl J Med. 2004;351(21):2203–17.
Minogiannis P, El Mansoury M, Betances JA, Sant GR, Theoharides TC. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol. 1998;20(10):553–63.
Theoharides TC, Sant GR. Hydroxyzine for symptomatic relief of interstitial cystitis symptoms. In: Sant GR, editor. Interstitial cystitis. Philadelphia: Lippincott-Raven; 1997. p. 241–6.
Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49(5A Suppl):108–10.
Lewi HJ. Cimetidine in the treatment of interstitial cystitis. Br J Urol. 1996;77(suppliment 1):28.
Seshadri P, Emerson L, Morales A. Cimetidine in the treatment of interstitial cystitis. Urology. 1994;44(4):614–6.
Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87:207–12.
Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P. Cimetidine in painful bladder syndrome: a histopathological study. BJU Int. 2001;88(3):183–6.
Tincello DG, Walker AC. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol. 2005;118(1):91–5.
Forsell TRMIH. Cyclosporine in severe interstitial cystitis. J Urol. 1996;155:1591.
Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004;171(6 Pt 1):2138–41.
Sairanen J, Tammela TL, Leppilahti M, Multanen M, Paananen I, Lehtoranta K, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235–8.
Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J Urol. 2000;164(6):1917–20.
Oravisto KJ, Alfthan OS. Treatment of interstitial cystitis with immunosuppression and chloroquine derivatives. Eur Urol. 1976;2(2):82–4.
Foster HESSWM. Nitric oxide and interstitial cystitis. Advances in Urology. 1997;10:1.
Smith SD, Wheeler MA, Foster Jr HE, Weiss RM. Improvement in interstitial cystitis symptom scores during treatment with oral l-arginine. J Urol. 1997;158(3 Pt 1):703–8.
Ehren I, Lundberg JO, Adolfsson J, Wiklund NP. Effects of l-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis. Urology. 1998;52(6):1026–9.
Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster Jr HE. A randomized double-blind trial of oral l-arginine for treatment of interstitial cystitis. J Urol. 1999;161(2):558–65.
Cartledge JJ, Davies AM, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of l-arginine in the treatment of interstitial cystitis. BJU Int. 2000;85(4):421–6.
Theoharides TC, Kempuraj D, Vakali S, Sant GR. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek—an oral multi-agent natural supplement. Can J Urol. 2008;15(6):4410–4.
Katske F, Shoskes DA, Sender M, Poliakin R, Gagliano K, Rajfer J. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol. 2001;7(1):44–6.
Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol. 2000;163(6):1685–8.
Burkhard FC, Blick N, Hochreiter WW, Studer UE. Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol. 2004;172(1):232–5.
Maskell R. Broadening the concept of urinary tract infection. Br J Urol. 1995;76:2–8.
Moran PA, Dwyer PL, Carey MP, Maher CF, Radford NJ. Oral methotrexate in the management of refractory interstitial cystitis. Aust N Z J Obstet Gynaecol. 1999;39(4):468–71.
Bouchelouche K, Nordling J, Hald T, Bouchelouche P. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Urology. 2001;57(6 Suppl 1):118.
Fleischmann J. Calcium channel antagonists in the treatment of interstitial cystitis. Urol Clin North Am. 1994;21(1):107–11.
Kelly JD, Young MR, Johnston SR, Keane PF. Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis. Eur Urol. 1998;34(1):53–6.
Hanno PM, Burks D, Clemens JQ, Dmochowski R, Erickson D, FitzGerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hanno, P.M. (2013). Oral Therapy for Bladder Pain Syndrome Directed at the Bladder. In: Nordling, J., Wyndaele, J., van de Merwe, J., Bouchelouche, P., Cervigni, M., Fall, M. (eds) Bladder Pain Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6929-3_21
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6929-3_21
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-6928-6
Online ISBN: 978-1-4419-6929-3
eBook Packages: MedicineMedicine (R0)